LAURA BRANDT: Open Payments
NPI 1013997899 · VANCOUVER, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,293 in 65 payments from 11 companies in 2025. Trend: 2023 $2,162 · 2024 $1,647 · 2025 $1,293
Food & beverage: $1,194Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $323 |
| UCB, Inc. | 15 | $317 |
| ABBVIE INC. | 14 | $279 |
| Galderma Laboratories, L.P. | 8 | $158 |
| Organon LLC | 4 | $46 |
| Amgen Inc. | 2 | $45 |
| Arcutis Biotherapeutics, Inc. | 1 | $36 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $33 |
| LEO Pharma Inc. | 1 | $20 |
| Incyte Corporation | 1 | $20 |
Products named: TREMFYA, Bimzelx, SKYRIZI, NEMLUVIO, OTEZLA, Zoryve, RINVOQ, ANZUPGO.
Industry payments across WA — which companies pay providers there.
